BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33587914)

  • 1. Identification of tumor-associated antigens of lung cancer: SEREX combined with bioinformatics analysis.
    Wang Y; Wang P; Liu M; Zhang X; Si Q; Yang T; Ye H; Song C; Shi J; Wang K; Wang X; Zhang J; Dai L
    J Immunol Methods; 2021 May; 492():112991. PubMed ID: 33587914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovering novel lung cancer associated antigens and the utilization of their autoantibodies in detection of lung cancer.
    Pei L; Liu H; Ouyang S; Zhao C; Liu M; Wang T; Wang P; Ye H; Wang K; Song C; Zhang J; Dai L
    Immunobiology; 2020 Mar; 225(2):151891. PubMed ID: 31839396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic efficiency of seven autoantibodies in lung cancer.
    Huang H; Luo W; Ni Y; Sun S; Wang C; Zhang L
    Eur J Cancer Prev; 2020 Jul; 29(4):315-320. PubMed ID: 31764214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.
    Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J
    Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Human esophageal carcinoma antigens screened by serologic analysis of recombinant cDNA expression libraries (SEREX)].
    Yu L; Hu H; Ran YL; Peng LP; Li JW; Yang ZH
    Ai Zheng; 2007 Jan; 26(1):100-5. PubMed ID: 17222377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of lung adenocarcinoma biomarkers based on bioinformatic analysis and human samples.
    Dong S; Men W; Yang S; Xu S
    Oncol Rep; 2020 May; 43(5):1437-1450. PubMed ID: 32323809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral immune response to epidermal growth factor receptor in lung cancer.
    Wang Y; Liu F; OuYang S; Liu M; Zhang X; Wang P; Zhao C; Zhang L; Dai L
    Immunol Res; 2021 Feb; 69(1):71-80. PubMed ID: 33495907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated TOP2A and UBE2C expressions correlate with poor prognosis in patients with surgically resected lung adenocarcinoma: a study based on immunohistochemical analysis and bioinformatics.
    Guo W; Sun S; Guo L; Song P; Xue X; Zhang H; Zhang G; Wang Z; Qiu B; Tan F; Xue Q; Gao Y; Gao S; He J
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):821-841. PubMed ID: 32103339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies against tumor-associated antigens in the early detection of lung cancer.
    Dai L; Tsay JC; Li J; Yie TA; Munger JS; Pass H; Rom WN; Zhang Y; Tan EM; Zhang JY
    Lung Cancer; 2016 Sep; 99():172-9. PubMed ID: 27565936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Diagnostic Model With IgM Autoantibodies and Carcinoembryonic Antigen for Early Detection of Lung Adenocarcinoma.
    Zhang X; Li J; Wang Y; Liu M; Liu F; Zhang X; Pei L; Wang T; Jiang D; Wang X; Zhang J; Dai L
    Front Immunol; 2021; 12():728853. PubMed ID: 35140701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal serum autoantibody repertoire profiling identifies surgery-associated biomarkers in lung adenocarcinoma.
    Li Y; Li CQ; Guo SJ; Guo W; Jiang HW; Li HC; Tao SC
    EBioMedicine; 2020 Mar; 53():102674. PubMed ID: 32113159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and Validation of Serum Autoantibodies Against Tumor-Associated Antigens as Biomarkers in Gastric Adenocarcinoma Based on the Focused Protein Arrays.
    Yang Q; Qin J; Sun G; Qiu C; Jiang D; Ye H; Wang X; Dai L; Zhu J; Wang P; Zhang J
    Clin Transl Gastroenterol; 2020 Dec; 12(1):e00284. PubMed ID: 33346593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma.
    Zhou SL; Yue WB; Fan ZM; Du F; Liu BC; Li B; Han XN; Ku JW; Zhao XK; Zhang P; Cui J; Zhou FY; Zhang LQ; Fan XP; Zhou YF; Zhu LL; Liu HY; Wang LD
    Dis Esophagus; 2014; 27(8):790-7. PubMed ID: 24147952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of human lung cancer antigens by serological screening with autologous antibodies.
    Hanafusa T; Mohamed AE; Kitaoka K; Ohue Y; Nakayama E; Ono T
    Cancer Lett; 2011 Feb; 301(1):57-62. PubMed ID: 21094583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are circulating autoantibodies to ABCC3 transporter a potential biomarker for lung cancer?
    Liu L; Liu N; Liu B; Yang Y; Zhang Q; Zhang W; Yu P; Jin Y; Guo J; Guan S; Sun S; Miao L; Wei J
    J Cancer Res Clin Oncol; 2012 Oct; 138(10):1737-42. PubMed ID: 22699933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of tumor-associated antigens based on Oncomine database and evaluation of diagnostic value of autoantibodies in lung cancer.
    Wang T; Liu H; Pei L; Wang K; Song C; Wang P; Ye H; Zhang J; Ji Z; Ouyang S; Dai L
    Clin Immunol; 2020 Jan; 210():108262. PubMed ID: 31629809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibody Response to ZRF1 and KRR1 SEREX Antigens in Patients with Breast Tumors of Different Histological Types and Grades.
    Dyachenko L; Havrysh K; Lytovchenko A; Dosenko I; Antoniuk S; Filonenko V; Kiyamova R
    Dis Markers; 2016; 2016():5128720. PubMed ID: 27847402
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of humoral response to tumor antigens using recombinant expression-based serological mini-arrays (SMARTA).
    Lagarkova MA; Koroleva EP; Kuprash DV; Boitchenko VE; Kashkarova UA; Nedospasov SA; Shebzukhov YV
    Immunol Lett; 2003 Jan; 85(1):71-4. PubMed ID: 12505200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of tumor antigens that elicit a humoral immune response in the sera of Chinese esophageal squamous cell carcinoma patients by modified serological proteome analysis.
    Gao H; Zheng Z; Mao Y; Wang W; Qiao Y; Zhou L; Liu F; He H; Zhao X
    Cancer Lett; 2014 Mar; 344(1):54-61. PubMed ID: 24157810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Protein Markers for the Early Detection of Lung Cancer: A Focus on Autoantibodies.
    Broodman I; Lindemans J; van Sten J; Bischoff R; Luider T
    J Proteome Res; 2017 Jan; 16(1):3-13. PubMed ID: 27769114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.